Private Equity Track record
  • Actionlogo Newmarch18
    Marken
    UK / Private Equity

    Services & Software

    Overview

    Marken is a specialist express logistics and support services provider to the biopharmaceutical industry. Its services include the movement of biological samples on a global basis, the export of trial medication, vaccines and clinical trial material, regulatory advice, protocol support, cold-chain management and investigator liaison.

    Highlights

    • Delivered an ambitious growth strategy and achieved a growth rate of over 30%
    • Increased operating margins through both revenue growth and cost savings
    • Strengthened the management team and introduced sector expert, Mel Porter, to the board as NXD
    • Leveraged 3i’s global network to support organic growth while actively seeking out bolt-on acquisitions
    • Established operations in China
    • Expanded US market share and targeted US-based pharma companies
    Key facts
    +30% Growth rate
    3.0x money multiple
    “3i managed to pre-empt what was going to be a highly competitive auction by the speed with which it completed its due diligence and was ready to execute a contract. 3i became the preferred acquirer with management, and was quickly able to conclude the deal." Jonathan Rowland, MD, Citigroup

    Regulatory information 
    This transaction involved a recommendation of 3i Investments plc.

Back to top